TLR4 and myocardial ischemia: Interestingly, MSC-Exo attenuates myocardial ischemia-reperfusion injury by enhancing M2 macrophages polarization through miRNA-182 and its downstream target, namely, toll-like receptor 4 (TLR4) (125).